Literature DB >> 7140824

Experimental infection of Bordetella bronchiseptica to rabbits.

H Yoda, K Nakayama, M Nakagawa.   

Abstract

Infectivity and pathogenicity of Bordetella bronchiseptica to rabbits were investigated by intranasal inoculation of the organism to suckling and young animals. Results are summarized as follows. 1. By inoculation of 5 X 10(4) and 10(6) organisms, the infection developed in 60% and 100% of young rabbits, respectively. 2. In young rabbits, the growth of the organism was evident in the trachea within 5 days after inoculation and in the lung on the 10th day. The organism began to disappear from the lung and trachea of some animals from the 40th day after inoculation, but remained in the external nares and nasal cavity of all animals even on the 90th day. Neither clinical sign nor pneumonic lesion was observed in any stages of the infection. 3. Pneumonic lesions and serous nasal secretion were found in all suckling rabbits by inoculation of 5 X 10(6) organisms, but no fatal case was detected.

Entities:  

Mesh:

Year:  1982        PMID: 7140824

Source DB:  PubMed          Journal:  Jikken Dobutsu        ISSN: 0007-5124


  4 in total

1.  Filamentous hemagglutinin of Bordetella bronchiseptica is required for efficient establishment of tracheal colonization.

Authors:  P A Cotter; M H Yuk; S Mattoo; B J Akerley; J Boschwitz; D A Relman; J F Miller
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

2.  Role of Bordetella bronchiseptica fimbriae in tracheal colonization and development of a humoral immune response.

Authors:  S Mattoo; J F Miller; P A Cotter
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity.

Authors:  E T Harvill; P A Cotter; M H Yuk; J F Miller
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  Study of a Bordetella hinzii isolate from a laboratory mouse.

Authors:  Nobuhito Hayashimoto; Masahiko Yasuda; Kazuo Goto; Akira Takakura; Toshio Itoh
Journal:  Comp Med       Date:  2008-10       Impact factor: 0.982

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.